0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global AAV Transfection Reagent Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-10N16939
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global AAV Transfection Reagent Market Research Report 2024
BUY CHAPTERS

Global AAV Transfection Reagent Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-10N16939
Report
November 2025
Pages:166
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

AAV Transfection Reagent Market

The global AAV Transfection Reagent market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
AAV (Adeno-Associated Virus) transfection reagents are specialized materials used in molecular biology and gene therapy research to introduce foreign genetic material into cells. Specifically, these reagents are designed to package and deliver nucleic acids, such as DNA or RNA, using the natural infection mechanism of AAVs. They are a vital tool in biomedical research, the study of gene function, the creation of stable cell lines for biopharmaceutical production, and the development of gene therapies for treating genetic disorders. The reagents typically consist of AAV vectors, which are modified viruses that can efficiently transduce a wide range of cell types without causing significant disease or damage.
From a downstream perspective, Laboratory accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
AAV Transfection Reagent leading manufacturers including Gibco, Mirus Bio, Polyplus, Cell Biolabs, Genemedi, Yeasen Biotechnology, OZ Biosciences, Promega, Takara Bio, SignaGen Laboratories, etc., dominate supply; the top five capture approximately % of global revenue, with Gibco leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global AAV Transfection Reagent market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of AAV Transfection Reagent Market Report

Report Metric Details
Report Name AAV Transfection Reagent Market
Segment by Type
  • Lab Size
  • Mass Production Size
Segment by Application
  • Laboratory
  • Hospital
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Gibco, Mirus Bio, Polyplus, Cell Biolabs, Genemedi, Yeasen Biotechnology, OZ Biosciences, Promega, Takara Bio, SignaGen Laboratories, System Bioscience, Vigene Biosciences, Engreen Biosystem, Beyotime Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the AAV Transfection Reagent study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the AAV Transfection Reagent Market report?

Ans: The main players in the AAV Transfection Reagent Market are Gibco, Mirus Bio, Polyplus, Cell Biolabs, Genemedi, Yeasen Biotechnology, OZ Biosciences, Promega, Takara Bio, SignaGen Laboratories, System Bioscience, Vigene Biosciences, Engreen Biosystem, Beyotime Biotech

What are the Application segmentation covered in the AAV Transfection Reagent Market report?

Ans: The Applications covered in the AAV Transfection Reagent Market report are Laboratory, Hospital, Others

What are the Type segmentation covered in the AAV Transfection Reagent Market report?

Ans: The Types covered in the AAV Transfection Reagent Market report are Lab Size, Mass Production Size

1 Study Coverage
1.1 Introduction to AAV Transfection Reagent: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global AAV Transfection Reagent Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Lab Size
1.2.3 Mass Production Size
1.3 Market Segmentation by Application
1.3.1 Global AAV Transfection Reagent Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Laboratory
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global AAV Transfection Reagent Revenue Estimates and Forecasts 2020-2031
2.2 Global AAV Transfection Reagent Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global AAV Transfection Reagent Sales Estimates and Forecasts 2020-2031
2.4 Global AAV Transfection Reagent Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global AAV Transfection Reagent Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global AAV Transfection Reagent Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Lab Size Market Size by Manufacturers
3.5.2 Mass Production Size Market Size by Manufacturers
3.6 Global AAV Transfection Reagent Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global AAV Transfection Reagent Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global AAV Transfection Reagent Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global AAV Transfection Reagent Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global AAV Transfection Reagent Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America AAV Transfection Reagent Sales and Revenue by Type (2020-2031)
6.4 North America AAV Transfection Reagent Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America AAV Transfection Reagent Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe AAV Transfection Reagent Sales and Revenue by Type (2020-2031)
7.4 Europe AAV Transfection Reagent Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe AAV Transfection Reagent Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific AAV Transfection Reagent Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific AAV Transfection Reagent Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific AAV Transfection Reagent Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America AAV Transfection Reagent Sales and Revenue by Type (2020-2031)
9.4 Central and South America AAV Transfection Reagent Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America AAV Transfection Reagent Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa AAV Transfection Reagent Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa AAV Transfection Reagent Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa AAV Transfection Reagent Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Gibco
11.1.1 Gibco Corporation Information
11.1.2 Gibco Business Overview
11.1.3 Gibco AAV Transfection Reagent Product Models, Descriptions and Specifications
11.1.4 Gibco AAV Transfection Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Gibco AAV Transfection Reagent Sales by Product in 2024
11.1.6 Gibco AAV Transfection Reagent Sales by Application in 2024
11.1.7 Gibco AAV Transfection Reagent Sales by Geographic Area in 2024
11.1.8 Gibco AAV Transfection Reagent SWOT Analysis
11.1.9 Gibco Recent Developments
11.2 Mirus Bio
11.2.1 Mirus Bio Corporation Information
11.2.2 Mirus Bio Business Overview
11.2.3 Mirus Bio AAV Transfection Reagent Product Models, Descriptions and Specifications
11.2.4 Mirus Bio AAV Transfection Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Mirus Bio AAV Transfection Reagent Sales by Product in 2024
11.2.6 Mirus Bio AAV Transfection Reagent Sales by Application in 2024
11.2.7 Mirus Bio AAV Transfection Reagent Sales by Geographic Area in 2024
11.2.8 Mirus Bio AAV Transfection Reagent SWOT Analysis
11.2.9 Mirus Bio Recent Developments
11.3 Polyplus
11.3.1 Polyplus Corporation Information
11.3.2 Polyplus Business Overview
11.3.3 Polyplus AAV Transfection Reagent Product Models, Descriptions and Specifications
11.3.4 Polyplus AAV Transfection Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Polyplus AAV Transfection Reagent Sales by Product in 2024
11.3.6 Polyplus AAV Transfection Reagent Sales by Application in 2024
11.3.7 Polyplus AAV Transfection Reagent Sales by Geographic Area in 2024
11.3.8 Polyplus AAV Transfection Reagent SWOT Analysis
11.3.9 Polyplus Recent Developments
11.4 Cell Biolabs
11.4.1 Cell Biolabs Corporation Information
11.4.2 Cell Biolabs Business Overview
11.4.3 Cell Biolabs AAV Transfection Reagent Product Models, Descriptions and Specifications
11.4.4 Cell Biolabs AAV Transfection Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Cell Biolabs AAV Transfection Reagent Sales by Product in 2024
11.4.6 Cell Biolabs AAV Transfection Reagent Sales by Application in 2024
11.4.7 Cell Biolabs AAV Transfection Reagent Sales by Geographic Area in 2024
11.4.8 Cell Biolabs AAV Transfection Reagent SWOT Analysis
11.4.9 Cell Biolabs Recent Developments
11.5 Genemedi
11.5.1 Genemedi Corporation Information
11.5.2 Genemedi Business Overview
11.5.3 Genemedi AAV Transfection Reagent Product Models, Descriptions and Specifications
11.5.4 Genemedi AAV Transfection Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Genemedi AAV Transfection Reagent Sales by Product in 2024
11.5.6 Genemedi AAV Transfection Reagent Sales by Application in 2024
11.5.7 Genemedi AAV Transfection Reagent Sales by Geographic Area in 2024
11.5.8 Genemedi AAV Transfection Reagent SWOT Analysis
11.5.9 Genemedi Recent Developments
11.6 Yeasen Biotechnology
11.6.1 Yeasen Biotechnology Corporation Information
11.6.2 Yeasen Biotechnology Business Overview
11.6.3 Yeasen Biotechnology AAV Transfection Reagent Product Models, Descriptions and Specifications
11.6.4 Yeasen Biotechnology AAV Transfection Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Yeasen Biotechnology Recent Developments
11.7 OZ Biosciences
11.7.1 OZ Biosciences Corporation Information
11.7.2 OZ Biosciences Business Overview
11.7.3 OZ Biosciences AAV Transfection Reagent Product Models, Descriptions and Specifications
11.7.4 OZ Biosciences AAV Transfection Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 OZ Biosciences Recent Developments
11.8 Promega
11.8.1 Promega Corporation Information
11.8.2 Promega Business Overview
11.8.3 Promega AAV Transfection Reagent Product Models, Descriptions and Specifications
11.8.4 Promega AAV Transfection Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Promega Recent Developments
11.9 Takara Bio
11.9.1 Takara Bio Corporation Information
11.9.2 Takara Bio Business Overview
11.9.3 Takara Bio AAV Transfection Reagent Product Models, Descriptions and Specifications
11.9.4 Takara Bio AAV Transfection Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Takara Bio Recent Developments
11.10 SignaGen Laboratories
11.10.1 SignaGen Laboratories Corporation Information
11.10.2 SignaGen Laboratories Business Overview
11.10.3 SignaGen Laboratories AAV Transfection Reagent Product Models, Descriptions and Specifications
11.10.4 SignaGen Laboratories AAV Transfection Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 SignaGen Laboratories Recent Developments
11.11 System Bioscience
11.11.1 System Bioscience Corporation Information
11.11.2 System Bioscience Business Overview
11.11.3 System Bioscience AAV Transfection Reagent Product Models, Descriptions and Specifications
11.11.4 System Bioscience AAV Transfection Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 System Bioscience Recent Developments
11.12 Vigene Biosciences
11.12.1 Vigene Biosciences Corporation Information
11.12.2 Vigene Biosciences Business Overview
11.12.3 Vigene Biosciences AAV Transfection Reagent Product Models, Descriptions and Specifications
11.12.4 Vigene Biosciences AAV Transfection Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Vigene Biosciences Recent Developments
11.13 Engreen Biosystem
11.13.1 Engreen Biosystem Corporation Information
11.13.2 Engreen Biosystem Business Overview
11.13.3 Engreen Biosystem AAV Transfection Reagent Product Models, Descriptions and Specifications
11.13.4 Engreen Biosystem AAV Transfection Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Engreen Biosystem Recent Developments
11.14 Beyotime Biotech
11.14.1 Beyotime Biotech Corporation Information
11.14.2 Beyotime Biotech Business Overview
11.14.3 Beyotime Biotech AAV Transfection Reagent Product Models, Descriptions and Specifications
11.14.4 Beyotime Biotech AAV Transfection Reagent Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Beyotime Biotech Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 AAV Transfection Reagent Industry Chain
12.2 AAV Transfection Reagent Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 AAV Transfection Reagent Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 AAV Transfection Reagent Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 AAV Transfection Reagent Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global AAV Transfection Reagent Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global AAV Transfection Reagent Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global AAV Transfection Reagent Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global AAV Transfection Reagent Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global AAV Transfection Reagent Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global AAV Transfection Reagent Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global AAV Transfection Reagent Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global AAV Transfection Reagent Sales by Region (2020-2025) & (K Units)
 Table 8. Global AAV Transfection Reagent Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global AAV Transfection Reagent Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global AAV Transfection Reagent Sales Share by Manufacturers (2020-2025)
 Table 12. Global AAV Transfection Reagent Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global AAV Transfection Reagent Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global AAV Transfection Reagent by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AAV Transfection Reagent as of 2024)
 Table 16. Global AAV Transfection Reagent Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global AAV Transfection Reagent Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers AAV Transfection Reagent Manufacturing Base and Headquarters
 Table 19. Global AAV Transfection Reagent Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global AAV Transfection Reagent Sales by Type (2020-2025) & (K Units)
 Table 23. Global AAV Transfection Reagent Sales by Type (2026-2031) & (K Units)
 Table 24. Global AAV Transfection Reagent Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global AAV Transfection Reagent Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global AAV Transfection Reagent ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global AAV Transfection Reagent Sales by Application (2020-2025) & (K Units)
 Table 29. Global AAV Transfection Reagent Sales by Application (2026-2031) & (K Units)
 Table 30. AAV Transfection Reagent High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global AAV Transfection Reagent Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global AAV Transfection Reagent Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global AAV Transfection Reagent ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America AAV Transfection Reagent Growth Accelerators and Market Barriers
 Table 37. North America AAV Transfection Reagent Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America AAV Transfection Reagent Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe AAV Transfection Reagent Growth Accelerators and Market Barriers
 Table 40. Europe AAV Transfection Reagent Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe AAV Transfection Reagent Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific AAV Transfection Reagent Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific AAV Transfection Reagent Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific AAV Transfection Reagent Growth Accelerators and Market Barriers
 Table 45. Southeast Asia AAV Transfection Reagent Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America AAV Transfection Reagent Investment Opportunities and Key Challenges
 Table 47. Central and South America AAV Transfection Reagent Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa AAV Transfection Reagent Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa AAV Transfection Reagent Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Gibco Corporation Information
 Table 51. Gibco Description and Major Businesses
 Table 52. Gibco Product Models, Descriptions and Specifications
 Table 53. Gibco Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Gibco Sales Value Proportion by Product in 2024
 Table 55. Gibco Sales Value Proportion by Application in 2024
 Table 56. Gibco Sales Value Proportion by Geographic Area in 2024
 Table 57. Gibco AAV Transfection Reagent SWOT Analysis
 Table 58. Gibco Recent Developments
 Table 59. Mirus Bio Corporation Information
 Table 60. Mirus Bio Description and Major Businesses
 Table 61. Mirus Bio Product Models, Descriptions and Specifications
 Table 62. Mirus Bio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Mirus Bio Sales Value Proportion by Product in 2024
 Table 64. Mirus Bio Sales Value Proportion by Application in 2024
 Table 65. Mirus Bio Sales Value Proportion by Geographic Area in 2024
 Table 66. Mirus Bio AAV Transfection Reagent SWOT Analysis
 Table 67. Mirus Bio Recent Developments
 Table 68. Polyplus Corporation Information
 Table 69. Polyplus Description and Major Businesses
 Table 70. Polyplus Product Models, Descriptions and Specifications
 Table 71. Polyplus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Polyplus Sales Value Proportion by Product in 2024
 Table 73. Polyplus Sales Value Proportion by Application in 2024
 Table 74. Polyplus Sales Value Proportion by Geographic Area in 2024
 Table 75. Polyplus AAV Transfection Reagent SWOT Analysis
 Table 76. Polyplus Recent Developments
 Table 77. Cell Biolabs Corporation Information
 Table 78. Cell Biolabs Description and Major Businesses
 Table 79. Cell Biolabs Product Models, Descriptions and Specifications
 Table 80. Cell Biolabs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Cell Biolabs Sales Value Proportion by Product in 2024
 Table 82. Cell Biolabs Sales Value Proportion by Application in 2024
 Table 83. Cell Biolabs Sales Value Proportion by Geographic Area in 2024
 Table 84. Cell Biolabs AAV Transfection Reagent SWOT Analysis
 Table 85. Cell Biolabs Recent Developments
 Table 86. Genemedi Corporation Information
 Table 87. Genemedi Description and Major Businesses
 Table 88. Genemedi Product Models, Descriptions and Specifications
 Table 89. Genemedi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Genemedi Sales Value Proportion by Product in 2024
 Table 91. Genemedi Sales Value Proportion by Application in 2024
 Table 92. Genemedi Sales Value Proportion by Geographic Area in 2024
 Table 93. Genemedi AAV Transfection Reagent SWOT Analysis
 Table 94. Genemedi Recent Developments
 Table 95. Yeasen Biotechnology Corporation Information
 Table 96. Yeasen Biotechnology Description and Major Businesses
 Table 97. Yeasen Biotechnology Product Models, Descriptions and Specifications
 Table 98. Yeasen Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Yeasen Biotechnology Recent Developments
 Table 100. OZ Biosciences Corporation Information
 Table 101. OZ Biosciences Description and Major Businesses
 Table 102. OZ Biosciences Product Models, Descriptions and Specifications
 Table 103. OZ Biosciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. OZ Biosciences Recent Developments
 Table 105. Promega Corporation Information
 Table 106. Promega Description and Major Businesses
 Table 107. Promega Product Models, Descriptions and Specifications
 Table 108. Promega Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Promega Recent Developments
 Table 110. Takara Bio Corporation Information
 Table 111. Takara Bio Description and Major Businesses
 Table 112. Takara Bio Product Models, Descriptions and Specifications
 Table 113. Takara Bio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Takara Bio Recent Developments
 Table 115. SignaGen Laboratories Corporation Information
 Table 116. SignaGen Laboratories Description and Major Businesses
 Table 117. SignaGen Laboratories Product Models, Descriptions and Specifications
 Table 118. SignaGen Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. SignaGen Laboratories Recent Developments
 Table 120. System Bioscience Corporation Information
 Table 121. System Bioscience Description and Major Businesses
 Table 122. System Bioscience Product Models, Descriptions and Specifications
 Table 123. System Bioscience Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. System Bioscience Recent Developments
 Table 125. Vigene Biosciences Corporation Information
 Table 126. Vigene Biosciences Description and Major Businesses
 Table 127. Vigene Biosciences Product Models, Descriptions and Specifications
 Table 128. Vigene Biosciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. Vigene Biosciences Recent Developments
 Table 130. Engreen Biosystem Corporation Information
 Table 131. Engreen Biosystem Description and Major Businesses
 Table 132. Engreen Biosystem Product Models, Descriptions and Specifications
 Table 133. Engreen Biosystem Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Engreen Biosystem Recent Developments
 Table 135. Beyotime Biotech Corporation Information
 Table 136. Beyotime Biotech Description and Major Businesses
 Table 137. Beyotime Biotech Product Models, Descriptions and Specifications
 Table 138. Beyotime Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. Beyotime Biotech Recent Developments
 Table 140. Key Raw Materials Distribution
 Table 141. Raw Materials Key Suppliers
 Table 142. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 143. Milestones in Production Technology Evolution
 Table 144. Distributors List
 Table 145. Market Trends and Market Evolution
 Table 146. Market Drivers and Opportunities
 Table 147. Market Challenges, Risks, and Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources


List of Figures
 Figure 1. AAV Transfection Reagent Product Picture
 Figure 2. Global AAV Transfection Reagent Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Lab Size Product Picture
 Figure 4. Mass Production Size Product Picture
 Figure 5. Global AAV Transfection Reagent Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Laboratory
 Figure 7. Hospital
 Figure 8. Others
 Figure 9. AAV Transfection Reagent Report Years Considered
 Figure 10. Global AAV Transfection Reagent Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global AAV Transfection Reagent Revenue (2020-2031) & (US$ Million)
 Figure 12. Global AAV Transfection Reagent Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global AAV Transfection Reagent Revenue Market Share by Region (2020-2031)
 Figure 14. Global AAV Transfection Reagent Sales (2020-2031) & (K Units)
 Figure 15. Global AAV Transfection Reagent Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 16. Global AAV Transfection Reagent Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers AAV Transfection Reagent Sales Volume Market Share in 2024
 Figure 18. Global AAV Transfection Reagent Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Lab Size Revenue Market Share by Manufacturer in 2024
 Figure 21. Mass Production Size Revenue Market Share by Manufacturer in 2024
 Figure 22. Global AAV Transfection Reagent Sales Market Share by Type (2020-2031)
 Figure 23. Global AAV Transfection Reagent Revenue Market Share by Type (2020-2031)
 Figure 24. Global AAV Transfection Reagent Sales Market Share by Application (2020-2031)
 Figure 25. Global AAV Transfection Reagent Revenue Market Share by Application (2020-2031)
 Figure 26. North America AAV Transfection Reagent Sales YoY (2020-2031) & (K Units)
 Figure 27. North America AAV Transfection Reagent Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers AAV Transfection Reagent Sales Revenue (US$ Million) in 2024
 Figure 29. North America AAV Transfection Reagent Sales Volume (K Units) by Type (2020- 2031)
 Figure 30. North America AAV Transfection Reagent Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America AAV Transfection Reagent Sales Volume (K Units) by Application (2020-2031)
 Figure 32. North America AAV Transfection Reagent Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US AAV Transfection Reagent Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada AAV Transfection Reagent Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico AAV Transfection Reagent Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe AAV Transfection Reagent Sales YoY (2020-2031) & (K Units)
 Figure 37. Europe AAV Transfection Reagent Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers AAV Transfection Reagent Sales Revenue (US$ Million) in 2024
 Figure 39. Europe AAV Transfection Reagent Sales Volume (K Units) by Type (2020-2031)
 Figure 40. Europe AAV Transfection Reagent Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe AAV Transfection Reagent Sales Volume (K Units) by Application (2020-2031)
 Figure 42. Europe AAV Transfection Reagent Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany AAV Transfection Reagent Revenue (2020-2031) & (US$ Million)
 Figure 44. France AAV Transfection Reagent Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. AAV Transfection Reagent Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy AAV Transfection Reagent Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia AAV Transfection Reagent Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific AAV Transfection Reagent Sales YoY (2020-2031) & (K Units)
 Figure 49. Asia-Pacific AAV Transfection Reagent Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers AAV Transfection Reagent Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific AAV Transfection Reagent Sales Volume (K Units) by Type (2020- 2031)
 Figure 52. Asia-Pacific AAV Transfection Reagent Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific AAV Transfection Reagent Sales Volume (K Units) by Application (2020-2031)
 Figure 54. Asia-Pacific AAV Transfection Reagent Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia AAV Transfection Reagent Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan AAV Transfection Reagent Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea AAV Transfection Reagent Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan AAV Transfection Reagent Revenue (2020-2031) & (US$ Million)
 Figure 59. India AAV Transfection Reagent Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America AAV Transfection Reagent Sales YoY (2020-2031) & (K Units)
 Figure 61. Central and South America AAV Transfection Reagent Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers AAV Transfection Reagent Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America AAV Transfection Reagent Sales Volume (K Units) by Type (2021-2031)
 Figure 64. Central and South America AAV Transfection Reagent Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America AAV Transfection Reagent Sales Volume (K Units) by Application (2020-2031)
 Figure 66. Central and South America AAV Transfection Reagent Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil AAV Transfection Reagent Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina AAV Transfection Reagent Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa AAV Transfection Reagent Sales YoY (2020-2031) & (K Units)
 Figure 70. Middle East and Africa AAV Transfection Reagent Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers AAV Transfection Reagent Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa AAV Transfection Reagent Sales Volume (K Units) by Type (2021-2031)
 Figure 73. South America AAV Transfection Reagent Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa AAV Transfection Reagent Sales Volume (K Units) by Application (2020-2031)
 Figure 75. Middle East and Africa AAV Transfection Reagent Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries AAV Transfection Reagent Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey AAV Transfection Reagent Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt AAV Transfection Reagent Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa AAV Transfection Reagent Revenue (2020-2025) & (US$ Million)
 Figure 80. AAV Transfection Reagent Industry Chain Mapping
 Figure 81. Regional AAV Transfection Reagent Manufacturing Base Distribution (%)
 Figure 82. Global AAV Transfection Reagent Production Market Share by Region (2020-2031)
 Figure 83. AAV Transfection Reagent Production Process
 Figure 84. Regional AAV Transfection Reagent Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure